Effect of body weight on testosterone/estradiol ratio in oligozoospermic patients

被引:87
作者
Fejes, I [1 ]
Koloszár, S [1 ]
Závaczki, Z [1 ]
Daru, J [1 ]
Szöllösi, J [1 ]
Pál, A [1 ]
机构
[1] Univ Szeged, Fac Med, Dept Obstet & Gynecol, H-6725 Szeged, Hungary
来源
ARCHIVES OF ANDROLOGY | 2006年 / 52卷 / 02期
关键词
body mass index; male fertility; oligozoospermia; testosterone/estradiol ratio;
D O I
10.1080/01485010500315479
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
To evaluate the effect of body mass on the hormonal and semen profiles of subfertile men with oligozoospemia, sperm concentration and reproductive hormone levels were compared in two body mass index (BMI) groups: underweight or normal weight patients ( BMI <= 25 kg/m(2)) vs. overweight or obese patients (BMI > 25 kg/m(2)). The mean BMI was 27 +/- 4.6 kg/m(2). The testosterone/ estradiol ratio was significantly reduced in the high BMI group as compared to the low BMI group ( 17 +/- 4 vs. 12 +/- 3; p < 0.05). A similar difference was found in the sperm concentration (11.2 +/- 3.16 x 10(6)/ml vs. 8.1 +/- 2.6 x 10(6)/ml). A nonsignificant difference was found in the LH/FSH ratio ( 1.41 +/- 0.64 vs. 1.63 +/- 0.72). We concluded that obesity and the consequent estrogen excess decrease the sperm concentration by influencing the hypothalamo-pituitary system.
引用
收藏
页码:97 / 102
页数:6
相关论文
共 18 条
[1]  
[Anonymous], 1999, WHO LAB MANUAL EXAMI, P4
[2]   The underlying basis for obesity: Relationship to cancer [J].
Bray, GA .
JOURNAL OF NUTRITION, 2002, 132 (11) :3451S-3455S
[3]   Evidence of free leptin in human seminal plasma [J].
Camiña, JP ;
Lage, M ;
Menendez, C ;
Graña, M ;
García-Devesa, J ;
Dieguez, C ;
Casanueva, FF .
ENDOCRINE, 2002, 17 (03) :169-174
[4]  
Carreau S, 1999, INT J ANDROL, V22, P211, DOI 10.1046/j.1365-2605.1999.00172.x
[5]   Reproductive system: aromatase and estrogens [J].
Carreau, S ;
Bourguiba, DS ;
Lambard, S ;
Galeraud-Denis, I ;
Genissel, C ;
Levallet, J .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 193 (1-2) :137-143
[6]   Aromatase, adiposity, aging and disease. The hypogonadal metabolic-atherogenic-disease and aging connection [J].
Cohen, PG .
MEDICAL HYPOTHESES, 2001, 56 (06) :702-708
[7]   Management strategies for male factor infertility [J].
Haidl, G .
DRUGS, 2002, 62 (12) :1741-1753
[8]   Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation [J].
Holbrook, JM ;
Cohen, PG .
SOUTHERN MEDICAL JOURNAL, 2003, 96 (06) :544-547
[9]   Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men [J].
Jensen, TK ;
Andersson, AM ;
Jorgensen, N ;
Andersen, AG ;
Carlsen, E ;
Petersen, JH ;
Skakkebæk, NE .
FERTILITY AND STERILITY, 2004, 82 (04) :863-870
[10]   Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility:: a randomized, double-blind, placebo-controlled, clinical trial [J].
Kamischke, A ;
Behre, HM ;
Bergmann, M ;
Simoni, M ;
Schäfer, T ;
Nieschlag, E .
HUMAN REPRODUCTION, 1998, 13 (03) :596-603